Application no. and date | 17204895.1 (espacenet) (Federated) (European Patent Register), 20040409 | Patent/reg. no. and date | DK/EP 3345895, 20191204 | Publication date | 20180711 | Priority no. and date | US 461988 P, 20030411 | EP pub. no. and date |
EP 3345895 20180711 | Effective date | | Applicant/owner | PTC Therapeutics, Inc., 100 Corporate Court, Middlesex Business Center South Plainfield, NJ 07080, US | Applicant ref. no. | P70826DK01 | Inventor | Moon, Young-Choon, 11 Edgewood Drive
Belle Meade, NJ New Jersey 08502, US, CHEN, Guangming, 932 Sunset Ridge
Bridgewater, NJ New Jersey 08807, US, Karp, Gary, Mitchell, 37 Cartwright Drive
Princeton Junction, NJ New Jersey 08550, US, Hwang, Seongwoo, 227 Suttons Lane
Edison, NJ New Jersey 08817, US, Almstead, Neil Gregory, 25 Hageman Lane
Princeton, NJ New Jersey 08540, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | Opponent | | IPC Class | A61K 31/4245 (2006.01) , A61P 27/02 (2006.01) , A61P 35/00 (2006.01) , C07D 271/06 (2006.01) | Title | 1,2,4-OXADIAZOL-BENZOESYREFORBINDELSE OG DENS ANVENDELSE TIL NONSENSE-UNDERTRYKKELSE OG BEHANDLINGEN AF SYGDOM | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|